Pipeline

EM Imaging Portfolio

Edinburgh Molecular Imaging as a portfolio of agents designed to improve diagnosis and treatment of Cancer and Lung Disease. All Optical Agents progressed to date have been found to be safe, specific, sensitive and selective.

EMI-137 (CRC Lesion) was previously known as GE-137. See related publications here.

adminPipeline